1H-Pyrrole-2,5-dione, 3-[1-[3-(dimethylamino)propyl]-5-methoxy-1H-indol-3-yl]-4-(1H-indol-3-yl)-, 96%, 1mg

2,5-Dimethyl-7,7,8,8-tetracyanoquinodimethane>98.0%(N)500mg

(R)-4-(tert-Butyl)-2-(1,8-naphthyridin-2-yl)-4,5-dihydrooxazole, 97%, 1g

N-(4-nitrophenyl)urea, 98.0%, 1g

Récipient à col large ROTILABO® PETG, 2000 ml, 4 Pièce(s)

2,4,6-Tribromoanisole, 98%, 100g

(3aR,7aR)-1,3-Bis(2-isopropylphenyl)-3a,4,5,6,7,7a-hexahydro-1H-benzo[d]imidazol-3-ium tetrafluoroborate, 98%, 100mg

3,5-Dimethoxytoluene>97.0%(GC)25g

(S)-2-Methylmorpholine, 95.0%, 10g

2-(2-((4-Fluorobenzyl)thio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)acetic acid, 97.0%, 5g

1-(4-isopropoxyphenyl)-5-oxopyrrolidine-3-carboxylic acid, 95.0%, 1g

2-(2-(Methylthio)phenoxy)acetic acid, 98%, 5g

(E)-2-Cyano-pent-2-enoic acid ethyl ester, 95.0%, 1g